Jason Shields

Jason Shields has been a medicinal chemist at AstraZeneca (Massachusetts site) for 10 years as of next Saturday. In that time he has worked on numerous projects in small molecule drug discovery for projects in Oncology, including Arginase, A2AR, POLQ, and HPK1. Alongside project work he has also 'worn hats' in green chemistry, cheminformatics, and artificial intelligence. Prior to AZ Jason was a post-doc with James Morken at Boston College, working on Pt-catalyzed diboration applications to total synthesis. He conducted his graduate studies with Abby Doyle at Princeton University, working on enantioselective nickel catalysis and air-stable nickel precatalysts.